Загрузка...
Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer
Both aptamers and siRNA technologies have now reached maturity, and both have been validated with a product in the market. However, although pegaptanib reached the market some time ago, there has been a slow process for new aptamers to follow. Today, some 40 aptamers are in the market, but many in c...
Сохранить в:
| Опубликовано в: : | Pharmaceutics |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956146/ https://ncbi.nlm.nih.gov/pubmed/31888119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11120684 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|